Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 4228 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#4228, RRID:AB_659940
- Product name
- Phospho-PI3 Kinase p85 (Tyr458)/p55 (Tyr199) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Mouse
- Host
- Rabbit
- Storage
- -20°C
Submitted references Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src.
Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways.
Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization.
Jung J, Kim HY, Kim M, Sohn K, Kim M, Lee K
Oncogene 2011 May 12;30(19):2264-74
Oncogene 2011 May 12;30(19):2264-74
Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
Gu M, Roy S, Raina K, Agarwal C, Agarwal R
Cancer research 2009 Dec 15;69(24):9465-72
Cancer research 2009 Dec 15;69(24):9465-72
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways.
Meng X, Shoemaker SF, McGee SO, Ip MM
Carcinogenesis 2008 May;29(5):1013-21
Carcinogenesis 2008 May;29(5):1013-21
Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization.
Lau C, Wang X, Song L, North M, Wiehler S, Proud D, Chow CW
Journal of immunology (Baltimore, Md. : 1950) 2008 Jan 15;180(2):870-80
Journal of immunology (Baltimore, Md. : 1950) 2008 Jan 15;180(2):870-80
No comments: Submit comment
No validations: Submit validation data